Table 2 Univariate and Multivariate Cox Proportional Hazard Analysis of Factors Associated With Time to Initiation of Therapy Among Persons Starting HAART During the Follow-up Period (n = 303)
Time to Initiation of Therapy | Unadjusted Hazard Ratio (95% CI) | Adjusted Hazard Ratio (95% CI) |
|---|---|---|
Sex (male vs female) | 0.92 (0.62–1.37) | -- |
Age (per 10 years) | 1.31 (1.09–1.57) | -- |
MSM Risk (yes vs no) | 0.77 (0.52–1.12) | -- |
IDU Risk (yes vs no) | 1.67 (0.93–2.99) | -- |
Prior AIDS-defining illness (yes vs no)* | 6.74 (4.21–10.80) | 4.28 (2.49–7.37) |
pVL (per log10 copies/mL increase) | 2.59 (1.87–3.58) | 2.17 (1.56–3.02) |
CD4 (per 100 cell/mcL decrease)* | 1.00 (0.99–1.01) | -- |